New biosensors quickly detect coronavirus proteins and antibodies
When mixed with fluid from a nasal swab or blood sample, these protein biosensors emit light within minutes. …
When mixed with fluid from a nasal swab or blood sample, these protein biosensors emit light within minutes. …
COVID-19 mortality rates were 13 times higher in pregnant mothers than in similarly aged individuals. …
A nanoparticle COVID-19 vaccine candidate produces virus-neutralizing antibodies in mice at levels ten-times greater than is seen in people who have recovered from COVID-19 infections. …
A CDC study looking at more than 80,000 adult patients hospitalized with influenza found that serious heart complications were common, occurring in 12 percent of patients. …
An antibody first identified in a blood sample from a patient who recovered from Severe Acute Respiratory Syndrome in 2003 inhibits related coronaviruses, including the cause of COVID-19. …
A recent study of over 1,000 healthy women with no symptoms of urinary tract infections showed nearly 9 percent carried multi-drug resistant E. coli strains in their guts. …
New findings show how a genetically aberrant, fused protein promotes a rare form of liver cancer in adolescents and young adults. …
With many disease-causing bacteria ratcheting up their shields against current drugs, new tactics are vital to protect people from treatment-resistant infections. …
According to the U.S. Centers for Disease Control and Prevention, about one in three humans carry Staphylococcus aureus, or “staph,” in our noses, and 2 percent of us carry the dreaded methicillin-resistant …
The risk of dementia, including Alzheimer’s, was significantly higher in people who had experienced a traumatic brain injury (TBI) than with people who had no history of TBI, …
End of content
End of content